Ovid Therapeutics Inc
Price
FilingsNewest: Form S-3, shelf registrationNov 10 →InsidersNo open-market buys. 2 insiders sold $29,286, 0 of 2 sales on a 10b5-1 plan.→HoldersJupiter Topco 11.0%Eventide 6.3%BlackRock 5.7%→Financing →PeersClosest companies: LONA, ALGS, MAZE→
From the filings
Figures
- Revenue
- $1.5Mlast 12 months
- Net income
- −$43.1Mlast 12 months
- Operating cash flow
- −$54.8Mlast 12 months
- Cash and equivalents
- $13.8Mat the last balance sheet
- Shares outstanding
- 188.7M shareson issue
Filings, newest first
- Nov 10S-3Shelf registration
- Nov 1010-QQuarterly report
- Nov 108-KResults of operations
- Aug 1310-QQuarterly report
- Aug 138-KFinancial statements and exhibits
- Jul 2913GStake over 5%, passive
- Jul 88-KDirector or officer change
- Jun 118-KShareholder vote
- Mar 1810-KAnnual report
- Mar 24Insider trade
- Mar 24Insider trade